About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Ataxia
Patient Information:
Treatment: Neural Growth Factor Therapy, supplemented with cerebral blood circulation improvement and nutritional therapy
Medical History:
Omar, a 35-year-old male, was admitted to Beijing Puhua International Hospital in June 2014. He reported decreased vision for the previous eight years and unsteady gait with slurred speech for the past three years. He was diagnosed with hereditary cerebellar ataxia.
Medical Condition before Treatment:
Treatment Course:
Omar underwent Neural Growth Factor Therapy, combined with additional treatments focusing on improving cerebral blood circulation and nutrition. This was supplemented with Traditional Chinese Medicine (TCM) and rehabilitation training.
Post-Treatment Updates:
Upon discharge, Omar demonstrated significant improvements in:
Post-Discharge Outlook:
Further changes would require follow-up assessment and cannot be predicted from this account.
Scan to connectSelect your language
